Anzeige
Mehr »
Login
Montag, 29.04.2024 Börsentäglich über 12.000 News von 686 internationalen Medien
Basin Uranium: Es geht los! Der Uran-Superzyklus ist gestartet!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
63 Leser
Artikel bewerten:
(0)

DSI Renal Unveils Newly Relocated Birmingham South Dialysis Clinic

BIRMINGHAM, Ala., June 1, 2012 /PRNewswire/ --DSI Renal, a leading provider of dialysis services for patients suffering from chronic kidney failure, today announced the opening of a newly relocated Birmingham dialysis clinic, DSI South Dialysis. The new facility, conveniently located near several hospital and health care systems on the Southside of the downtown Birmingham area, replaces the former DSI Norwood clinic. DSI South Dialysis will host an Open House event on Tuesday, June 5, from 4 pm to 6 pm CT for patients, physicians and other visitors interested in seeing the new state-of-the-art facility.

"We are extremely pleased to open the doors of this impressive new location, which offers a number of substantial updates for existing and prospective patients," said Birmingham native Jason Gunter, who is Executive Vice President & Chief Operating Officer at DSI Renal. "While we will continue to offer the same level of exceptional medical care, the new facility is indisputably more inviting, convenient and accessible than our prior location."

The new DSI South clinic, located at 3201 3rd Avenue South, is situated in the highly visible and established medical district across from Baptist Health System and near St. Vincent's, UAB and Brookwood medical centers. Patient amenities include heated massage chairs, individual station flat-screen TVs, flexible scheduling and plenty of free, private parking. DSI South also offers peritoneal dialysis training for in-home treatment and maximum patient convenience.

"DSI South is a prime example of continued revitalization on the Southside of downtown Birmingham," said Merrimon Epps of Barber Companies, developer and owner of the DSI South property. "We were thrilled to work with DSI Renal to create a contemporary facility perfectly suited to their needs, which we also believe is contributing to the overall advancement and beautification of the area."

Existing and prospective patients, physicians, media and the public are welcome and encouraged to attend the DSI South Dialysis Open House on June 5th. No RSVP is necessary.

About DSI Renal
DSI Renal (formed as Dialysis Newco, Inc.) is a leading provider of dialysis services in the United States, offering state-of-the-art treatment for patients suffering from chronic kidney failure and renal disease. Together with its physician partners, DSI Renal owns and operates 85 dialysis clinics in 23 states. The company plans for growth through acquisition and development of new clinics as well as through establishment of additional joint venture partnerships with leading nephrologists for the clinic, hospital and alternate settings. For more information, please visit www.dsi-corp.com.

Clinic Contact:
Showanda Carter-Walker
DSI South
(205) 502-5300
Admissions: (888) 293-0394

Corporate Contact:
Giles Ward
DSI Renal
(615) 777-8200
gward@dsi-corp.com

Media Contact:
Angela Novak
Corner Office Communications
(615) 406-0715
anovak@cornerofficecommunication.com

SOURCE DSI Renal

Großer Insider-Report 2024 von Dr. Dennis Riedl
Wenn Insider handeln, sollten Sie aufmerksam werden. In diesem kostenlosen Report erfahren Sie, welche Aktien Sie im Moment im Blick behalten und von welchen Sie lieber die Finger lassen sollten.
Hier klicken
© 2012 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.